Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

5.94 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -463.661-328.066-239.476-186.479-87.006-61.879
Depreciation & Amortization 36.49424.40211.7568.4054.4422.489
Deferred Income Tax 0000.8271.7571.054
Stock Based Compensation 81.68853.50327.90914.8424.2921.385
Change In Working Capital 0-50.257104.921-0.30630.8340.408
Accounts Receivables 00-0.0020.114-0.005-0.027
Inventory 000.0027.8354.3570
Accounts Payables 6.435-0.9871.7671.745-0.185-0.34
Other Working Capital -38.365-49.27103.154-1026.6670.775
Other Non Cash Items -13.69512.63811.3664.0970.282-0.499
Operating Cash Flow -359.174-287.78-83.524-158.614-45.399-57.042
Investing Activities:
Investments In Property Plant And Equipment -13.695-11.955-37.359-39.798-6.735-3.91
Acquisitions Net 277.1041.8440231.946-2.60
Purchases Of Investments 000-301.13700
Sales Maturities Of Investments 00.48230.60869.19100
Other Investing Activites -3.35-0.597230.308-231.9460.5950
Investing Cash Flow 260.059-10.228193.249-271.744-8.74-3.91
Financing Activities:
Debt Repayment -4.44-0.766-0.09-12.7986.3230.705
Common Stock Issued 300.417128.093143.711462.901239.812119.705
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 8.14312.80610.7248.437239.812119.705
Financing Cash Flow 304.12140.133154.345458.54246.135120.41
Other Information:
Effect Of Forex Changes On Cash -3.4060.188-0.307000
Net Change In Cash 201.599-157.687263.76328.182191.99659.458
Cash At End Of Period 603.024401.425559.112295.349267.16775.171